Skip to main content
Erschienen in: Pediatric Surgery International 3/2012

01.03.2012 | Original Article

Glutamine prevents intestinal mucosal injury induced by cyclophosphamide in rats

verfasst von: Mitsugu Owari, Masafumi Wasa, Takaharu Oue, Satoko Nose, Masahiro Fukuzawa

Erschienen in: Pediatric Surgery International | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Purpose

High doses of anticancer drugs often damage the intestinal mucosa. The purpose of the present study was to examine the effect of glutamine on mucosal damage induced by cyclophosphamide in a rat model, and to elucidate the mechanisms responsible for its protective effects.

Method

Rats were randomly assigned to one of the three experimental groups. Group A (control) (n = 8): intraperitoneal injection of saline, group B (n = 8): intraperitoneal injection of cyclophosphamide (300 mg/kg), group C (n = 8): intraperitoneal injection of cyclophosphamide (300 mg/kg) and oral glutamine (1.0 g/kg). After 3 days, the ileal segment was removed for morphological and the biochemical analyses. We also evaluated the level of mucosal apoptosis by the TUNEL method and enterocyte proliferation using bromodeoxyuridine (BrdU).

Results

Mucosal atrophy was observed in group B but not in groups A or C. The mucosal wet weight, protein and glutathione levels were significantly decreased in group B compared with group A, and were increased significantly in group C compared with group B. While enterocyte proliferation significantly decreased and the apoptotic index significantly increased in group B compared with group A, a significant increase in the enterocyte proliferation and a significant decrease in apoptosis were observed in group C compared with group B.

Conclusions

Glutamine prevented intestinal mucosal injury induced by cyclophosphamide via increased glutathione, decreased apoptosis and increased proliferation of intestinal epithelial cells.
Literatur
1.
Zurück zum Zitat Santos GW (1990) Bone marrow transplantation in hematologic malignancies. Current status. Cancer 65(3 Suppl):786–791PubMedCrossRef Santos GW (1990) Bone marrow transplantation in hematologic malignancies. Current status. Cancer 65(3 Suppl):786–791PubMedCrossRef
2.
Zurück zum Zitat Daniele B, Secondulfo M, De Vivo R, Pignata S, De Magistris L, Delrio P, Palaia R, Barletta E, Tambaro R, Carratu R (2001) Effect of chemotherapy with 5-fluorouracil on intestinal permeability and absorption in patients with advanced colorectal cancer. J Clin Gastroenterol 32(3):228–230PubMedCrossRef Daniele B, Secondulfo M, De Vivo R, Pignata S, De Magistris L, Delrio P, Palaia R, Barletta E, Tambaro R, Carratu R (2001) Effect of chemotherapy with 5-fluorouracil on intestinal permeability and absorption in patients with advanced colorectal cancer. J Clin Gastroenterol 32(3):228–230PubMedCrossRef
3.
Zurück zum Zitat Duncan M, Grant G (2003) Oral and intestinal mucositis—causes and possible treatments. Aliment Pharmacol Ther 18(9):853–874PubMedCrossRef Duncan M, Grant G (2003) Oral and intestinal mucositis—causes and possible treatments. Aliment Pharmacol Ther 18(9):853–874PubMedCrossRef
4.
Zurück zum Zitat Duggan C, Gannon J, Walker WA (2002) Protective nutrients and functional foods for the gastrointestinal tract. Am J Clin Nutr 75(5):789–808PubMed Duggan C, Gannon J, Walker WA (2002) Protective nutrients and functional foods for the gastrointestinal tract. Am J Clin Nutr 75(5):789–808PubMed
5.
Zurück zum Zitat Oehler R, Roth E (2003) Regulative capacity of glutamine. Curr Opin Clin Nutr Metab Care 6(3):277–282PubMed Oehler R, Roth E (2003) Regulative capacity of glutamine. Curr Opin Clin Nutr Metab Care 6(3):277–282PubMed
6.
Zurück zum Zitat Ziegler TR, Mantell MP, Chow JC, Rombeau JL, Smith RJ (1996) Gut adaptation and the insulin-like growth factor system: regulation by glutamine and igf-i administration. Am J Physiol 271(5 Pt 1):G866–G875 Ziegler TR, Mantell MP, Chow JC, Rombeau JL, Smith RJ (1996) Gut adaptation and the insulin-like growth factor system: regulation by glutamine and igf-i administration. Am J Physiol 271(5 Pt 1):G866–G875
7.
Zurück zum Zitat Anderson PM, Schroeder G, Skubitz KM (1998) Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy. Cancer 83(7):1433–1439PubMedCrossRef Anderson PM, Schroeder G, Skubitz KM (1998) Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy. Cancer 83(7):1433–1439PubMedCrossRef
8.
Zurück zum Zitat Daniele B, Perrone F, Gallo C, Pignata S, De Martino S, De Vivo R, Barletta E, Tambaro R, Abbiati R, D’Agostino L (2001) Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial. Gut 48(1):28–33PubMedCrossRef Daniele B, Perrone F, Gallo C, Pignata S, De Martino S, De Vivo R, Barletta E, Tambaro R, Abbiati R, D’Agostino L (2001) Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial. Gut 48(1):28–33PubMedCrossRef
9.
Zurück zum Zitat Neu J, DeMarco V, Li N (2002) Glutamine: clinical applications and mechanisms of action. Curr Opin Clin Nutr Metab Care 5(1):69–75PubMedCrossRef Neu J, DeMarco V, Li N (2002) Glutamine: clinical applications and mechanisms of action. Curr Opin Clin Nutr Metab Care 5(1):69–75PubMedCrossRef
10.
Zurück zum Zitat Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150(1):76–85PubMedCrossRef Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150(1):76–85PubMedCrossRef
11.
Zurück zum Zitat Song D, Shi B, Xue H, Li Y, Yang X, Yu B, Xu Z, Liu F, Li J (2006) Confirmation and prevention of intestinal barrier dysfunction and bacterial translocation caused by methotrexate. Dig Dis Sci 51(9):1549–1556PubMedCrossRef Song D, Shi B, Xue H, Li Y, Yang X, Yu B, Xu Z, Liu F, Li J (2006) Confirmation and prevention of intestinal barrier dysfunction and bacterial translocation caused by methotrexate. Dig Dis Sci 51(9):1549–1556PubMedCrossRef
12.
Zurück zum Zitat Paulus SC, van Saene HK, Hemsworth S, Hughes J, Ng A, Pizer BL (2005) A prospective study of septicaemia on a paediatric oncology unit: a three-year experience at The Royal Liverpool Children’s Hospital, Alder Hey, UK. Eur J Cancer 41(14):2132–2140PubMedCrossRef Paulus SC, van Saene HK, Hemsworth S, Hughes J, Ng A, Pizer BL (2005) A prospective study of septicaemia on a paediatric oncology unit: a three-year experience at The Royal Liverpool Children’s Hospital, Alder Hey, UK. Eur J Cancer 41(14):2132–2140PubMedCrossRef
13.
Zurück zum Zitat Clavijo J, Gomez-de-Segura IA, Gomez-Garcia L, Vallejo-Cremades MT, Sanchez M, de Miguel E (2004) Growth hormone protects the intestines but not the tumour from 5-fluorouracil toxicity in the short term in the rat. Eur J Gastroenterol Hepatol 16(1):75–82PubMedCrossRef Clavijo J, Gomez-de-Segura IA, Gomez-Garcia L, Vallejo-Cremades MT, Sanchez M, de Miguel E (2004) Growth hormone protects the intestines but not the tumour from 5-fluorouracil toxicity in the short term in the rat. Eur J Gastroenterol Hepatol 16(1):75–82PubMedCrossRef
14.
Zurück zum Zitat Kucuk C, Ozkan M, Akgun H, Muhtaroglu S, Sozuer E (2005) The effect of granulocyte macrophage-colony stimulating factor on bacterial translocation after administration of 5-fluorouracil in rats. J Surg Res 128(1):15–20PubMedCrossRef Kucuk C, Ozkan M, Akgun H, Muhtaroglu S, Sozuer E (2005) The effect of granulocyte macrophage-colony stimulating factor on bacterial translocation after administration of 5-fluorouracil in rats. J Surg Res 128(1):15–20PubMedCrossRef
15.
Zurück zum Zitat Nose S, Wasa M, Tazuke Y, Owari M, Fukuzawa M (2010) Cisplatin upregulates glutamine transport in human intestinal epithelial cells: the protective mechanism of glutamine on intestinal mucosa after chemotherapy. JPEN J Parenter Enteral Nutr 34(5):530–537 Nose S, Wasa M, Tazuke Y, Owari M, Fukuzawa M (2010) Cisplatin upregulates glutamine transport in human intestinal epithelial cells: the protective mechanism of glutamine on intestinal mucosa after chemotherapy. JPEN J Parenter Enteral Nutr 34(5):530–537
16.
Zurück zum Zitat Arrick BA, Nathan CF (1984) Glutathione metabolism as a determinant of therapeutic efficacy: a review. Cancer Res 44(10):4224–4232PubMed Arrick BA, Nathan CF (1984) Glutathione metabolism as a determinant of therapeutic efficacy: a review. Cancer Res 44(10):4224–4232PubMed
17.
Zurück zum Zitat Mitchell JB, Russo A (1987) The role of glutathione in radiation and drug induced cytotoxicity. Br J Cancer Suppl 8:96–104PubMed Mitchell JB, Russo A (1987) The role of glutathione in radiation and drug induced cytotoxicity. Br J Cancer Suppl 8:96–104PubMed
18.
Zurück zum Zitat Russo A, Carmichael J, Friedman N, DeGraff W, Tochner Z, Glatstein E, Mitchell JB (1986) The roles of intracellular glutathione in antineoplastic chemotherapy. Int J Radiat Oncol Biol Phys 12(8):1347–1354PubMedCrossRef Russo A, Carmichael J, Friedman N, DeGraff W, Tochner Z, Glatstein E, Mitchell JB (1986) The roles of intracellular glutathione in antineoplastic chemotherapy. Int J Radiat Oncol Biol Phys 12(8):1347–1354PubMedCrossRef
19.
Zurück zum Zitat Rabik CA, Dolan ME (2007) Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev 33(1):9–23PubMedCrossRef Rabik CA, Dolan ME (2007) Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev 33(1):9–23PubMedCrossRef
20.
Zurück zum Zitat Hong RW, Rounds JD, Helton WS, Robinson MK, Wilmore DW (1992) Glutamine preserves liver glutathione after lethal hepatic injury. Ann Surg 215(2):114–119PubMedCrossRef Hong RW, Rounds JD, Helton WS, Robinson MK, Wilmore DW (1992) Glutamine preserves liver glutathione after lethal hepatic injury. Ann Surg 215(2):114–119PubMedCrossRef
21.
Zurück zum Zitat Tazuke Y, Wasa M, Shimizu Y, Wang HS, Okada A (2003) Alanyl-glutamine-supplemented parenteral nutrition prevents intestinal ischemia–reperfusion injury in rats. JPEN J Parenter Enteral Nutr 27(2):110–115PubMedCrossRef Tazuke Y, Wasa M, Shimizu Y, Wang HS, Okada A (2003) Alanyl-glutamine-supplemented parenteral nutrition prevents intestinal ischemia–reperfusion injury in rats. JPEN J Parenter Enteral Nutr 27(2):110–115PubMedCrossRef
22.
Zurück zum Zitat Satoh J, Tsujikawa T, Fujiyama Y, Bamba T (2003) Nutritional benefits of enteral alanyl-glutamine supplementation on rat small intestinal damage induced by cyclophosphamide. J Gastroenterol Hepatol 18(6):719–725PubMedCrossRef Satoh J, Tsujikawa T, Fujiyama Y, Bamba T (2003) Nutritional benefits of enteral alanyl-glutamine supplementation on rat small intestinal damage induced by cyclophosphamide. J Gastroenterol Hepatol 18(6):719–725PubMedCrossRef
23.
Zurück zum Zitat Cerchietti LC, Navigante AH, Lutteral MA, Castro MA, Kirchuk R, Bonomi M, Cabalar ME, Roth B, Negretti G, Sheinker B, Uchima P (2006) Double-blinded, placebo-controlled trial on intravenous l-alanyl-l-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys 65(5):1330–1337PubMedCrossRef Cerchietti LC, Navigante AH, Lutteral MA, Castro MA, Kirchuk R, Bonomi M, Cabalar ME, Roth B, Negretti G, Sheinker B, Uchima P (2006) Double-blinded, placebo-controlled trial on intravenous l-alanyl-l-glutamine in the incidence of oral mucositis following chemoradiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys 65(5):1330–1337PubMedCrossRef
Metadaten
Titel
Glutamine prevents intestinal mucosal injury induced by cyclophosphamide in rats
verfasst von
Mitsugu Owari
Masafumi Wasa
Takaharu Oue
Satoko Nose
Masahiro Fukuzawa
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
Pediatric Surgery International / Ausgabe 3/2012
Print ISSN: 0179-0358
Elektronische ISSN: 1437-9813
DOI
https://doi.org/10.1007/s00383-011-3023-0

Weitere Artikel der Ausgabe 3/2012

Pediatric Surgery International 3/2012 Zur Ausgabe

Review Article

Prune belly syndrome

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.